EBS - What's Going On With Emergent Biosolutions Stock? | Benzinga
Emergent Biosolutions Inc (NYSE: EBS) shares initially traded higher Tuesday before pulling back and turning negative. The company received a $75 million contract option from the Biomedical Advanced Research and Development Authority (BARDA).
What Happened: BARDA awarded Emergent Biosolutions a $75 million option to the company's existing contract for the acquisition of newly licensed anthrax vaccine CYFENDUS. Deliveries are expected ...